Piper Sandler maintains overweight on Inspire Medical stock
Piper Sandler reaffirmed its positive stance on Inspire Medical Systems (NYSE:NYSE:INSP), maintaining an Overweight rating with a $260.00 price target. The endorsement comes after a steep 14.15% ...
Future Market Insights2d
Sleep Apnea Implants Industry to Reach USD 1,158.1 Million by 2033 at a 13.8% of CAGR
The global sleep apnea implants market is expected to grow from USD 317.1 million in 2023 to USD 1,158.1 million by 2033, at ...
Inspire Medical Systems: Hold Rating Amidst Competitive Challenges and Minimal Domestic Growth
Leerink Partners analyst Mike Kratky has maintained their neutral stance on INSP stock, giving a Hold rating on January 13.Stay Ahead of the ...
Inspire Medical Systems: Strong Q4 Sales Beat Expectations Amid Competitive and Organizational Uncertainties
Wells Fargo analyst Larry Biegelsen maintained a Hold rating on Inspire Medical Systems (INSP – Research Report) yesterday and set a price ...